GABAergic interneurons at supraspinal and spinal levels differentially modulate the antinociceptive effect of nitrous oxide in Fischer rats

Anesthesiology

Volumn 98, Issue 5, 2003, Pages 1223-1230

  Orii, Ryo ^a   Ohashi, Yoko ^a   Halder, Sunil ^a   Giombini, Mariangela ^a   Maze, Mervyn ^a   Fujinaga, Masahiko ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINO 2 (3 CARBOXYPROPYL) 6 (4 METHOXYPHENYL)PYRIDAZINIUM BROMIDE; DIAMINOBENZIDINE; MIDAZOLAM; MUSCIMOL; NITROUS OXIDE; PROTEIN C FOS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; GABAERGIC SYSTEM; IMMUNOHISTOCHEMISTRY; INTERNEURON; MALE; NEUROMODULATION; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANALGESICS, NON-NARCOTIC; ANIMALS; BRAIN; GABA ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; INJECTIONS, SPINAL; INTERNEURONS; MALE; MUSCIMOL; NITROUS OXIDE; PAIN, POSTOPERATIVE; RATS; RATS, INBRED F344; SPINAL CORD;

EID: 0242584848     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200305000-00026     Document Type: Article

References (38)

1. Fujinaga M, Maze M: Neurobiology of nitrous oxide-induced antinociceptive effects. Mol Neurobiol 2002; 25:167-89
2. Basbaum AL, Fields HL: Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci 1984; 7:309-38
3. Zhang C, Davies MF, Guo TZ, Maze M: The analgesic action of nitrous oxide is dependent on the release of norepinephrine in the dorsal horn of the spinal cord. ANESTHESIOLOGY 1999; 91:1401-7
4. Hashimoto T, Maze M, Ohashi Y, Fujinaga M: Nitrous oxide activates GABAergic neurons in the spinal cord in Fischer rats. ANESTHESIOLOGY 2001; 95:463-9
5. Fender C, Fujinaga M, Maze M: Strain differences in the antinociceptive effect of nitrous oxide on the tail flick test in rats. Anesth Analg 2000; 90:195-9
6. Paxinos G, Watson C: The rat brain in stereotaxic co-ordinates, 2nd edition. Sydney, Academic Press, 1986
7. Hough LB, Nalwalk JW, Leurs R, Menge WM, Timmerman H: Significance of GABAergic systems in the action of improgan, a non-opioid analgesic. Life Sci 2001; 68:2751-7
8. Hylden JL, Wilcox GL: Intrathecal morphine in mice: a new technique. Eur J Pharm 1980; 67:313-6
9. Mestre C, Pelissier T, Fialip J, Wilcox G, Eschalier A: A method to perform direct transcutaneous intrathecal injection in rats. J Pharm Toxicol Meth 1994; 32:197-200
10. Monnikes H, Lauer G, Bauer C, Tebbe J, Zittel TT, Arnold R: Pathways of Fos expression in locus ceruleus, dorsal vagal complex, and PVN in response to intestinal lipid. Am J Physiol 1997; 273:2059-71
11. Hahn MK, Bannon MJ: Stress-induced c-fos expression in the rat locus coeruleus is dependent on neurokinin 1 receptor activation. Neuroscience 1999; 94:1183-8
12. Li C, Chen P, Smith MS: Corticotropin releasing hormone neurons in the paraventricular nucleus are direct targets for neuropeptide Y neurons in the arcuate nucleus: an anterograde tracing study. Brain Res 2000; 854:122-9
13. Hunt SP, Pini A, Evan G: Induction of c-fos-like protein in spinal cord neurons following sensory stimulation. Nature 1987; 328:632-4
14. Harris JA: Using c-fos as a neural marker of pain. Brain Res Bull 1998; 45:1-8
15. Presley RW, Menetrey D, Levine JD, Basbaum AI: Systemic morphine suppresses noxious stimulus-evoked Fos protein-like immunoreactivity in the rat spinal cord. J Neurosci 1990; 10:323-35
16. Guo TZ, Poree L, Golden W, Stein J, Fujinaga M, Maze M: Antinociceptive response to nitrous oxide is mediated by supraspinal opiate and spinal alpha 2 adrenergic receptors in the rat. ANESTHESIOLOGY 1996; 854:846-52
17. 2B adrenoceptors. J Neurosci 2000; 20:9242-51
18. Takano M, Takano Y, Yaksh TL: Release of calcitonin gene-related peptide (CGRP), substance P (SP), and vasoactive intestinal polypeptide (VIP) from rat spinal cord: modulation by alpha 2 agonists. Peptides 1993; 14:371-8
19. Murata K, Nakagawa I, Kumeta Y, Kitahata LM, Collins JG: Intrathecal clonidine suppresses noxiously evoked activity of spinal wide dynamic range neurons in cats. Anesth Analg 1989; 69:185-91
20. Orii R, Ohashi Y, Guo T, Laura E. Nelson, Hashimoto T, Maze M, Fujinaga M: Evidence for the involvement of spinal cord α1 adrenoceptors in nitrous oxide-induced antinociceptive effects of in Fischer rats. ANESTHESIOLOGY 2002; 97:1458-65
21. Charney DS, Mihic SJ, Harris RA: Hypnotics and sedatives, Goodman & Gilman's The Pharmacological Basis of Therapeutics, 10th Ed. Edited by Hardman JG, Limbird LE.A New York, McGraw-Hill, 2001, pp. 399-427
22. Clark FM, Proudfit HK: The projection of noradrenergic neurons in the A7 catecholamine cell group to the spinal cord in the rat demonstrated by anterograde tracing combined with immunocytochemistry. Brain Res 1991; 547:279-88
23. Proudfit HK, Clark FM: The projections of locus coeruleus neurons to the spinal cord. Prog Brain Res 1991; 88:123-41
24. Fritsky JM, Grazanna R: Demonstration of two separate descending noradrenergic pathways to the rat spinal cord: evidence for an intragriseal trajectory of locus coeruleus axons in the superficial layers of the dorsal horn. J Comp Neurol 1990; 291:553-82
25. Clark FM, Proudfit HK: Anatomical evidence for genetic differences in the innervation of the rat spinal cord by noradrenergic locus coeruleus neurons. Brain Res 1992; 59:44-53
26. Clark FM, Proudfit HK: The projections of noradrenergic neurons in the A5 catecholamine cell group to the spinal cord in the rat: anatomical evidence that A5 neurons modulate nociception. Brain Res 1993; 616:200-10
27. Sluka KA, Westlund KN: Spinal projections of the locus coeruleus and the nucleus subcoeruleus in the Harlan and the Sasco Sprague-Dawley rat. Brain Res 1992; 579:67-73
28. Dirig DM, Yaksh TL: Intrathecal baclofen and muscimol, but not midazolam, are antinociceptive using the rat-formalin model. J Pharm Exp Ther 1995; 275:219-27
29. Luger TJ, Hayashi T, Lorenz IH, Hill HF: Mechanisms of the influence of midazolam on morphine antinociception at spinal and supraspinal levels in rats. Eur J Pharm 1994; 271:421-31
30. Luger TJ, Hayashi T, Weiss CG, Hill HF: The spinal potentiating effect and the supraspinal inhibitory effect of midazolam on opioid-induced analgesia in rats. Eur J Pharm 1995; 275:153-62
31. Daniels S, Smith EB: Effects of general anaeshetics on ligand-gated ion channels. Br J Anaesth 1993; 71:59-64
32. Goto T, Marota JJ, Crosby G: Nitrous oxide induces preemptive analgesia in the rat that is antagonized by halothane. ANESTHESIOLOGY 1994; 80:409-16
33. Goto T, Marota JJ, Crosby G: Volatile anaesthetics antagonize nitrous oxide and morphine-induced analgesia in the rat. Br J Anaesth 1996; 76:702-6
34. Janiszewski DJ, Galinkin JL, Klock PA, Coalson DW, Pardo H, Zacny JP: The effects of subanesthetic concentrations of sevoflurane and nitrous oxide, alone and in combination, on analgesia, mood, and psychomotor performance in healthy volunteers. Anesth Analg 1999; 88:1149-54.
35. A receptors at supraspinal level. Eur J Pharm 1999; 370:9-15
36. Hugo S, Lake APJ, Cooledge BA: Are barbiturates hyperalgesic? Anesthesiology 1994; 80:1413-4
37. Ewen A, Archer DP, Samanani N, Roth SH: Hyperalgesia during sedation: effects of barbiturates and propofol in the rat. Can J Anaesth 1995; 42:532-40
38. A receptor involvement. Braz J Med Biol Res 1997; 30:251-6